|Day Low/High||47.00 / 48.90|
|52 Wk Low/High||26.31 / 53.99|
After the strong run of homebuilders in 2019, the sector simply isn't as oversold as it was to start the year.
The prospect of improved housing activity thanks to mortgage rates that are down from a year ago could benefit these stocks.
I'm looking forward to hearing from Progenics Pharmaceuticals and Builders FirstSource.
Entercom, Builders FirstSource and PBF Energy all have positive catalysts that could help them take off soon.
Mortgage rates have been declining of late, which should help produce a better story for the housing market in the second part of 2019.
Builder confidence has ticked up of late heading into the crucial spring selling season.
Despite the January rally, this biotech name and building materials firm still have further to rise.
Bad news appears fully priced into these equities.
Lannett Co. and Builders FirstSource have seen insiders make purchases at recent low valuations.
Betting on negative reaction to the Fed has not worked well in the past.
Traders who have bought on morning weakness and sold on afternoon strength may be sorry at some point.
This week we'll get regional economic and housing data, a GDP report plus fourth-quarter earnings.
Holding an above-average cash position after peeling profits off the table into the most recent rally.
We used this week's declines to add to our positions in Teligent, Builders FirstSource and Sonus Networks.
Plus 303 more value destroyers, and what you can do to make money from this list.
It's well positioned to ride the market's surge.
The continued growth in housing starts is a good sign for homebuilders in the new year, says Stocks Under $10 Portfolio Manager David Peltier.
With the Q2 in the books, TheStreet's Lindsey Bell and Andrew Krill look ahead to what Q3 will bring.